UPC Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: February 11, 2026
Report Source: 2025 Annual Report
Universe Pharmaceuticals Inc. Stock Analysis UPC
Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 216 full-time employees. The company went IPO on 2021-03-23. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The firm is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.
Read More Universe Pharmaceuticals Inc (UPC) Chart
Key Statistics of Universe Pharmaceuticals Inc (UPC)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$2.65Volume
5029.00P/E Ratio (TTM)
-52 Week Range
Market Cap
1.73MAvg. Volume
14.00KDividend Yield
-Financial Metrics & Statements of Universe Pharmaceuticals Inc (UPC)
FAQ's for Universe Pharmaceuticals Inc (UPC)
- According to Musaffa’s Shariah screening methodology, Universe Pharmaceuticals Inc (UPC) is currently classified as NOT HALAL as of February 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.